Federated Hermes
ZBIO

Federated Hermes’s Zenas BioPharma ZBIO Stock Holding History

Federated Hermes’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.1M Sell
3,116,805
-10,226
-0.3% -$203K 0.11% 201
2026
Q1 		$61.1M Buy
3,127,031
+411,453
+15% +$9.24M 0.1% 224
2025
Q4 		$98.6M Buy
2,715,578
+853,740
+46% +$28.1M 0.16% 150
2025
Q3 		$41.3M Hold
1,861,838
– – 0.07% 306
2025
Q2 		$18M Buy
1,861,838
+703,838
+61% +$6.85M 0.03% 448
2025
Q1 		$9.15M Hold
1,158,000
– – 0.02% 577
2024
Q4 		$9.48M Hold
1,158,000
– – 0.02% 556
2024
Q3 		$19.6M Buy
+1,158,000
New +$20.8M 0.04% 436

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes's ZBIO Position: Q2 2026 in Review

Federated Hermes reduced its Zenas BioPharma (ZBIO) stake by 0.33% in Q2 2026, selling an estimated $203K and leaving 3,116,805 shares worth $79.1M. The position accounts for 0.11% of the portfolio, ranked #201.

Federated Hermes first reported a position in ZBIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $98.6M in Q4 2025. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Federated Hermes held 3,116,805 shares of Zenas BioPharma worth $79.1M as of Q2 2026.
  • Federated Hermes sold 10,226 Zenas BioPharma shares in Q2 2026, an estimated $203K.
  • Zenas BioPharma made up 0.11% of Federated Hermes's portfolio in Q2 2026, its #201 holding.
  • Federated Hermes first reported a position in Zenas BioPharma in Q3 2024 and has held it in 8 quarters since.
  • Federated Hermes's Zenas BioPharma position peaked at $98.6M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.